Europe Multiomics Market Size & Outlook, 2023-2030

The multiomics market in Europe is expected to reach a projected revenue of US$ 1,701.9 million by 2030. A compound annual growth rate of 14% is expected of Europe multiomics market from 2024 to 2030.
Revenue, 2023 (US$M)
$679.4
Forecast, 2030 (US$M)
$1,701.9
CAGR, 2024 - 2030
14%
Report Coverage
Europe

Europe multiomics market highlights

  • The Europe multiomics market generated a revenue of USD 679.4 million in 2023.
  • The market is expected to grow at a CAGR of 14% from 2024 to 2030.
  • In terms of segment, product was the largest revenue generating product & service in 2023.
  • Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.

Europe data book summary

Market revenue in 2023USD 679.4 million
Market revenue in 2030USD 1,701.9 million
Growth rate14% (CAGR from 2023 to 2030)
Largest segmentProduct
Fastest growing segmentServices
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationServices, Product
Key market players worldwideThermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group

Other key industry trends

  • In terms of revenue, Europe region accounted for 28.9% of the global multiomics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,158.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Multiomics Market Companies

Name Profile # Employees HQ Website

Europe multiomics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.


Product was the largest segment with a revenue share of 60.01% in 2023. Horizon Databook has segmented the Europe multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe Multiomics Product & Service Outlook (Revenue, USD Million, 2018-2030)
    • Services
    • Product
      • Instruments
      • Consumables
      • Software
  • Europe Multiomics Type Outlook (Revenue, USD Million, 2018-2030)
    • Single-cell Multiomics
    • Bulk Multiomics
  • Europe Multiomics Platform Outlook (Revenue, USD Million, 2018-2030)
    • Genomics
    • Transcriptomics
    • Proteomics
    • Metabolomics
    • Integrated Omics Platforms
  • Europe Multiomics Application Outlook (Revenue, USD Million, 2018-2030)
    • Cell Biology
    • Oncology
    • Neurology
    • Immunology
  • Europe Multiomics End Use Outlook (Revenue, USD Million, 2018-2030)
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Others

Reasons to subscribe to Europe multiomics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe multiomics market databook

  • Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe multiomics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe multiomics market size, by country, 2018-2030 (US$M)

Europe Multiomics Market Outlook Share, 2023 & 2030 (US$M)

Europe multiomics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more